Cancer Therapeutics - Market Research, Industry Trends, Market Share


Published: 11/12/2015
Pages: 320
Full Study Price: US$ 3,000

The World Market for Cancer Therapeutics: Forecasts to 2020 examines the trends that are currently shaping the cancer therapeutics industry, providing readers with an in-depth and comprehensive analysis of the market for cancer treatments, with a special emphasis on novel treatments. Market information in this report includes: cancer market drivers and barriers; market estimates and forecasts for novel therapies and traditional treatments; specific product revenues and market share; market analysis by product; market size and estimates by cancer type; market analysis by development stage; corporate profiles; and analyst conclusions. Information in The World Market for Cancer Therapeutics: Forecasts to 2020 was gathered using both primary and secondary research which include comprehensive research of secondary sources.
Our Simple Buying Process

Choose License and Add
This Report To Your Cart.

Register, Checkout
and Verify Payment.

Receive Notification When
Your Report Is Available.

Table Of Contents

  • Executive Summary
    • INTRODUCTION
    • SCOPE AND METHODOLOGY
    • SIZE AND GROWTH OF THE MARKET
      • Table Global Market for Novel Cancer Therapies, 2010-2020 (in millions of dollars)
  • Novel and Traditional Approaches
    • WHAT IS CANCER
      • Biochemistry of Cancer Cells
      • Carcinogen Metabolism
      • Causes of Cancer Growth
        • Table Viruses Associated with Cancer in Humans
    • HISTORY AND GROWTH OF THE CANCER TREATMENT MARKET
    • HOW PERSONALIZED MEDICINE IS CHANGING THE CANCER MARKET
    • TARGETED CANCER THERAPY
    • GENETIC TESTING IN CANCER
    • INDUSTRY STRUCTURE
    • CANCER TREATMENT APPROACHES: TRADITIONAL VS. NOVEL
    • PRODUCT EXAMPLES
      • Monoclonal Antibodies
      • Tyrosine Kinase Inhibitors
      • Cancer Vaccines
      • Cytokines
      • Gene Therapy
      • Other Novel Classifications
  • Market Drivers / Barriers
    • GLOBAL CANCER IMPACT
      • Table Global Cancer Incidence by Selected Types of Cancer, 2012 and 2025, all races, all ages, both genders
      • Table Most Common Cancer by Region and Gender
    • LIFE EXPECTANCY AND CANCER
      • Table Five-year Net Survival Rates* (%) for Selected Cancers among Adults 15 Years of Age and Older in Select Countries, Average 2005-2009
      • The United States - The Real Cost of Cancer
    • CURING CANCER THE ULTIMATE GOAL
    • THE COST OF CANCER THERAPIES
    • HEALTHY PEOPLE 2020
    • MARKETING AND DISTRIBUTION TRENDS
    • ELDERLY CLINICAL TRIAL INVOLVEMENT
    • DEVELOPMENT RISK
      • Development Risk in Novel Cancer Therapy Research Allovectin-7
    • DEVELOPMENT PROGRAMS
    • WHAT DOES THE NOVEL THERAPY DEVELOPMENT PIPELINE LOOK LIKE?
      • Recent NDA Activity
        • Table Select NDA Activity: 2015
      • New Indications
        • Table Select New Indications, 2015
      • Reaching the Market: Regulatory Accelerated Approvals and Priority Reviews
    • DEVELOPMENT AND MARKETING AGREEMENTS
    • INSURANCE AND REIMBURSEMENT ISSUES
  • Novel Therapies in Bladder Cancer Treatment
    • BLADDER CANCER OVERVIEW
    • TRENDS IN INCIDENCE AND MORTALITY
    • TREATING BLADDER CANCER
    • NOVEL TREATMENT RESEARCHACTIVITIES
      • Developer Participation
    • BLADDER CANCER TREATMENT MARKET AND OPPORTUNITY
      • Novel Treatment Outlook
  • Novel Therapies in Brain Cancer Treatment
    • BRAIN CANCER OVERVIEW
    • TRENDS IN INCIDENCE AND MORTALITY
    • TREATING BRAIN CANCER
    • NOVEL TREATMENT RESEARCHACTIVITIES
      • Developer Participation
    • BRAIN CANCER TREATMENT MARKET AND OPPORTUNITY
      • Novel Treatment Outlook
  • Novel Therapies in Breast Cancer Treatment
    • BREAST CANCER OVERVIEW
    • TRENDS IN INCIDENCE AND MORTALITY
    • TREATING BREAST CANCER
    • NOVEL TREATMENT RESEARCHACTIVITIES
      • Developer Participation
    • BREAST CANCER TREATMENT MARKET AND OPPORTUNITY
      • Novel Treatment Outlook
      • Leading Products and Suppliers
  • Novel Therapies in Colorectal Cancer Treatment
    • COLORECTAL CANCER OVERVIEW
    • TRENDS IN INCIDENCE AND MORTALITY
    • TREATING COLORECTAL CANCER
    • NOVEL TREATMENT RESEARCHACTIVITIES
      • Developer Participation
    • COLORECTAL CANCER TREATMENT MARKET AND OPPORTUNITY
      • Novel Treatment Outlook
      • Leading Products and Suppliers
        • Table Leading Novel Products in Colorectal Cancer Treatment based on Revenues, 2010-2015
  • Novel Therapies in Kidney Cancer Treatment
    • KIDNEY CANCER OVERVIEW
    • TRENDS IN INCIDENCE AND MORTALITY
    • TREATING KIDNEY CANCER
    • NOVEL TREATMENT RESEARCHACTIVITIES
      • Developer Participation
    • KIDNEY CANCER TREATMENT MARKET AND OPPORTUNITY
      • Novel Treatment Outlook
      • Leading Products and Suppliers
        • Table Leading Novel Products in Kidney Cancer Treatment based on Revenues, 2010-2015
  • Novel Therapies in Leukemia Treatment
    • LEUKEMIA CANCER OVERVIEW
      • Table Leukemia Overview by Type
    • TRENDS IN INCIDENCE AND MORTALITY
    • TREATING LEUKEMIA
    • NOVEL TREATMENT RESEARCHACTIVITIES
      • Developer Participation
    • LEUKEMIA TREATMENT MARKET AND OPPORTUNITY
      • Novel Treatment Outlook
      • Leading Products and Suppliers
  • Novel Therapies in Liver Cancer Treatment
    • LIVER CANCER OVERVIEW
    • TRENDS IN INCIDENCE AND MORTALITY
    • TREATING LIVER CANCER
    • NOVEL TREATMENT RESEARCHACTIVITIES
      • Developer Participation
    • LIVER CANCER TREATMENT MARKET AND OPPORTUNITY
      • Novel Treatment Outlook
  • Novel Therapies in Lung Cancer Treatment
    • LUNG CANCER OVERVIEW
      • Table Types of Primary Lung Cancer
    • TRENDS IN INCIDENCE AND MORTALITY
    • TREATING LUNG CANCER
    • NOVEL TREATMENT RESEARCHACTIVITIES
      • Developer Participation
    • LUNG CANCER TREATMENT MARKET AND OPPORTUNITY
      • Novel Treatment Outlook
      • Leading Products and Suppliers
  • Novel Therapies in Lymphoma Treatment
    • LYMPHOMA OVERVIEW
      • Table Classification of Non-Hodgkin's Lymphomas
    • TRENDS IN INCIDENCE AND MORTALITY
    • TREATING LYMPHOMA
    • NOVEL TREATMENT RESEARCHACTIVITIES
      • Developer Participation
    • LYMPHOMA TREATMENT MARKET AND OPPORTUNITY
      • Novel Treatment Outlook
      • Leading Products and Suppliers
  • Novel Therapies in Melanoma Treatment
    • MELANOMA OVERVIEW
      • Table Malignant Conditions of the Skin
    • TRENDS IN INCIDENCE AND MORTALITY
    • TREATING MELANOMA
    • NOVEL TREATMENT RESEARCHACTIVITIES
      • Developer Participation
    • MELANOMA TREATMENT MARKET AND OPPORTUNITY
      • Novel Treatment Outlook
      • Leading Products and Suppliers
  • Novel Therapies in Multiple Myeloma Treatment
    • MYELOMA OVERVIEW
    • TRENDS IN INCIDENCE AND MORTALITY
    • TREATING MULTIPLE MYELOMA
    • NOVEL TREATMENT RESEARCHACTIVITIES
      • Developer Participation
    • MULTIPLE MYELOMA TREATMENT MARKET AND OPPORTUNITY
      • Novel Treatment Outlook
      • Leading Products and Suppliers
        • Table Leading Novel Products in Multiple Myeloma Treatment based on Revenues, 2010-2015
  • Novel Therapies in Pancreatic Cancer Treatment
    • PANCREATIC CANCER OVERVIEW
    • TRENDS IN INCIDENCE AND MORTALITY
    • TREATING PANCREATIC CANCER
    • NOVEL TREATMENT RESEARCHACTIVITIES
      • Developer Participation
    • PANCREATIC CANCER TREATMENT MARKET AND OPPORTUNITY
      • Novel Treatment Outlook and Suppliers' Market Impact
  • Novel Therapies in Prostate Cancer Treatment
    • PROSTATE CANCER OVERVIEW
    • TRENDS IN INCIDENCE AND MORTALITY
    • TREATING PROSTATE CANCER
    • NOVEL TREATMENT RESEARCHACTIVITIES
      • Developer Participation
    • PROSTATE CANCER TREATMENT MARKET AND OPPORTUNITY
      • Novel Treatment Outlook and Suppliers' Market Impact
  • Novel Cancer Therapies: Market Summary
    • OVERVIEW
    • HOW HAVE NOVEL THERAPIES SHAPED THE MARKET AND WHAT'S IN STORE FOR THE FUTURE?
      • Table Novel Cancer Therapies, Global Market Value by Classification, 2010-2020 (in millions of dollars)
    • NOVEL THERAPIES AND ITS IMPACT ON INDIVIDUAL CANCER MARKETS
    • GEOGRAPHICAL MARKET AND TRENDS
    • COMPETITIVE LANDSCAPE
      • Table Novel Cancer Therapy Market, Leading Suppliers' Shares by Market Revenues, 2015 (in millions of dollars)
  • Market Participants and Key Developers
    • INTRODUCTION
    • ABBVIE
    • ACERTA PHARMA
    • ADAPTIMMUNE
    • ADVANTAGENE
    • ALTOR BIOSCIENCE
    • AMGEN
    • APCETH GMBH&CO. KG
    • ARRAY BIOPHARMA
    • ASTEX PHARMACEUTICALS
    • ASTRAZENECA PLC
    • BAYER
    • BELLICUM PHARMACEUTICALS, INC.
    • BIOCANCELL LTD.
    • BLUEBIRD BIO
    • BOEHRINGER INGELHEIM
    • BOSTON BIOMEDICAL
    • BRISTOL-MYERS SQUIBB COMPANY
    • CALADRIUS (NEOSTEM)
    • CELGENE
    • CELLDEX THERAPEUTICS
    • CELSION CORPORATION
    • CLOVIS ONCOLOGY
    • COLD GENESYS, INC.
    • DAIICHI SANKYO
    • EISAI
    • ELI LILLY &COMPANY
    • EMD SERONO
    • GALENA BIOPHARMA
    • GAMIDA CELL
    • GENPREX, INC.
    • GILEAD SCIENCES
    • IMMUNOMEDICS
    • INCYTE
    • INOVIO
    • JOHNSON &JOHNSON
    • JUNO THERAPEUTICS
    • KARYOPHARM THERAPEUTICS
    • MAXIVAX
    • MEDIMMUNE
    • MERCK&COMPANY
    • MILLENNIUM (TAKEDA ONCOLOGY)
    • MOMOTARO-GENE, INC.
    • MULTIVIR, INC.
    • NORTHWEST BIOTHERAPEUTICS
    • NOVARTIS
    • ONCOLYTICS BIOTECH
    • ONCOMED
    • ONCOSECMEDICAL, INC.
    • PFIZER, INC.
    • ROCHE
    • SANOFI
    • SEATTLE GENETICS
    • SEVION THERAPEUTICS
    • TAKARA BIO
    • TOCAGEN
    • VBLTHERAPEUTICS
    • ZIOPHARM ONCOLOGY, INC.
  • Information Sources